Auro Laboratories Fair Value
Auro Laboratories (AUROLAB) average fair value is ₹88.48 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹233.65 (-62.13%), fair value range ₹21.7–₹301.3. For live price and a broader fundamental view, visit Auro Laboratories share price screener.
Fair Value Analysis Export
AUROLAB Fair Value vs Current Price — Valuation Summary
AUROLAB average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). Explore Auro Laboratories intrinsic worth to estimate fundamental worth using multiple valuation models.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
AUROLAB Fair Value Analysis — Data Sources & Coverage
Auro Laboratories financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Review Auro Laboratories P/E valuation to evaluate earnings-based valuation against sector peers.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
AUROLAB vs Healthcare Sector Peers — P/E, P/B & Market Cap
Auro Laboratories P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Syngene International | SYNGENE | 72.83 | 3.32 | ₹16,034 |
| Jeena Sikho Lifecare | JSLL | 27.19 | 13.76 | ₹6,314 |
| Sun Pharmaceutical | SUNPHARMA | 37.64 | 5.46 | ₹456,449 |
| Kerala Ayurveda | KERALAYUR | -9.29 | 21.5 | ₹246 |
| Sat Kartar Life | SATKARTAR | 12.32 | 3.08 | ₹218 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.